Head-To-Head Comparison: DTE Energy (NYSE:DTE) and Biotricity (NYSE:BTCY)

DTE Energy (NYSE:DTE) and Biotricity (OTCMKTS:BTCY) are both utilities companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Earnings & Valuation

This table compares DTE Energy and Biotricity’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DTE Energy $14.21 billion 1.71 $1.12 billion $6.30 21.00
Biotricity N/A N/A N/A N/A N/A

DTE Energy has higher revenue and earnings than Biotricity.


This table compares DTE Energy and Biotricity’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DTE Energy 8.09% 10.33% 3.06%
Biotricity N/A N/A N/A


DTE Energy pays an annual dividend of $3.78 per share and has a dividend yield of 2.9%. Biotricity does not pay a dividend. DTE Energy pays out 60.0% of its earnings in the form of a dividend. DTE Energy has raised its dividend for 7 consecutive years.

Insider & Institutional Ownership

71.0% of DTE Energy shares are owned by institutional investors. Comparatively, 0.0% of Biotricity shares are owned by institutional investors. 0.6% of DTE Energy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations for DTE Energy and Biotricity, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DTE Energy 2 5 4 0 2.18
Biotricity 0 0 0 0 N/A

DTE Energy presently has a consensus target price of $127.80, suggesting a potential downside of 3.39%. Given DTE Energy’s higher probable upside, equities research analysts clearly believe DTE Energy is more favorable than Biotricity.

Volatility & Risk

DTE Energy has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 4.5, meaning that its share price is 350% more volatile than the S&P 500.


DTE Energy beats Biotricity on 10 of the 12 factors compared between the two stocks.

About DTE Energy

DTE Energy Company engages in the utility operations. The company's Electric segment generates, purchases, distributes, and sells electricity to approximately 2.2 million residential, commercial, and industrial customers in southeastern Michigan. It generates electricity through fossil-fuel, hydroelectric pumped storage, and nuclear plants, as well as wind and other renewable assets. This segment owns and operates approximately 696 distribution substations and 442,700 line transformers. The company's Gas segment purchases, stores, transports, distributes, and sells natural gas to approximately 1.3 million residential, commercial, and industrial customers throughout Michigan; and sells storage and transportation capacity. This segment has approximately 19,800 miles of distribution mains; 1,305,000 service pipelines; and 1,273,000 active meters, as well as owns approximately 2,000 miles of transmission pipelines. Its Gas Storage and Pipelines segment owns natural gas storage fields, lateral and gathering pipeline systems, and compression and surface facilities, as well as has ownership interests in interstate pipelines serving the Midwest, Ontario, and northeast markets. The company's Power and Industrial Projects segment offers metallurgical coke; pulverized coal and petroleum coke to the steel, pulp and paper, and other industries; and power, steam and chilled water production, and wastewater treatment services, as well as supplies compressed air to industrial customers. It also owns and operates 5 renewable generating plants with a capacity of 217 MWs; 23 landfill gas recovery sites; and 10 reduced emissions fuel facilities. Its Energy Trading segment engages in power and gas marketing and trading; structured transactions; and the optimization of contracted natural gas pipeline transportation and storage positions. The company was founded in 1903 and is headquartered in Detroit, Michigan.

About Biotricity

Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, focuses on providing biometric data monitoring solutions in the United States. The company focuses to deliver remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It is developing Bioflux mobile cardiac telemetry solution that provides recurring reimbursements to doctors, hospitals, and independent diagnostic testing facilities; revenue model that fits within the established insurance billing practices; built-in cellular connectivity; and motion tracking to detect exercise, activity, and disorientation. The company is also developing Biolife, a health and lifestyle solution for individuals. It has a collaboration agreement with the University of Calgary to determine the predictive value of electrocardiogram readings in preventative healthcare applications. Biotricity, Inc. is based in Redwood City, California.

Receive News & Ratings for DTE Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DTE Energy and related companies with MarketBeat.com's FREE daily email newsletter.